Trials / Completed
CompletedNCT03409874
Dry Needling and Spinal Manipulation vs. Interocclusal Appliance (Splint), NSAIDs and Joint Mobs for Temporomandibular Dysfunction
Dry Needling and Spinal Manipulation or Interocclusal Appliance (Splint), NSAIDs and Joint Mobs for Temporomandibular Dysfunction
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Alabama Physical Therapy & Acupuncture · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research is to compare two different approaches for treating patients with temporomandibular dysfunction (TMD): Dry needling and spinal manipulation or Interocclusal Appliance (Splint), NSAIDs and Temporomandibular Joint Mobilization . Clinicians commonly use all of these techniques to treat TMD. This study is attempting to find out if one treatment strategy is more effective than the other.
Detailed description
Patients with stress temporomandibular dysfunction will be randomized to receive 1-2 treatment sessions per week for up to 4 weeks ( up to 8 sessions total) of either: (1) dry needling and spinal manipulation or (2) Interocclusal appliance (splint), NSAIDs, temporomandibular joint mobilization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Dry Needling | Dry needling to the muscle of mastication and temporomandibular joint capsule. 1-2 treatment sessions per week for up to 4 weeks |
| OTHER | Spinal manipulation | Spinal manipulation, targeting the upper cervical spine (C1-C2, C2-C3 or OA). 1-2 treatments per week for up to 4 weeks. |
| OTHER | Interocclusal Appliance | Interocclusal appliance worn every nights for 4 weeks. |
| DRUG | NSAIDs | diclofenac (Voltaren) 3 X 50mg per day for 4 weeks. If the patient's TMJ pain improves, the dosage may be reduced to 2 X 50mg per day. |
| OTHER | TMJ Mobs | Temporomandibular joint mobilization targeting the temporomandibular joint capsule. 1-2 treatments per week for up to 4 weeks. |
Timeline
- Start date
- 2018-02-01
- Primary completion
- 2020-07-01
- Completion
- 2020-07-01
- First posted
- 2018-01-24
- Last updated
- 2020-12-29
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT03409874. Inclusion in this directory is not an endorsement.